Drug · DIN 02427184
VIMIZIM
5 MG/5 ML SINGLE-USE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 27, 2014; first marketed August 27, 2014.
- Drug Identification Number (DIN)
- 02427184
- Company (DIN owner)
- Biomarin International LimitedRingaskiddy, Cork, Ireland
- Schedule
- Schedule d; Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Elosulfase alfa A16AB12
- Class
- Human
- Record last updated
- August 4, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ELOSULFASE ALFA | 1 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 2, 2014: NOC 15768New Drug Submission (NDS)